Associations Between Mean HbA1c, HbA1c Variability, and Both Mortality and Macrovascular Complications in Patients with Diabetes Mellitus: A Registry-Based Cohort Study

References

• Huang ES, Davis AM. Glycemic control in older adults with diabetes mellitus. JAMA. 2015;314(14):1509. doi:10.1001/jama.2015.8345
   PubMed Web of Science ®Google Scholar
• Arnold LW, Wang Z. The HbA1c and all-cause mortality relationship in patients with type 2 diabetes is j-shaped: a meta-analysis of observational studies. Rev Diabet Stud. 2014;11(2):138–152. doi:10.1900/RDS.2014.11.138
   PubMedGoogle Scholar
• Huang ES, Liu JY, Moffet HH, John PM, Karter AJ. Glycemic control, complications, and death in older diabetic patients: the diabetes and aging study. Diabetes Care. 2011;34(6):1329–1336. doi:10.2337/dc10-2377
   PubMed Web of Science ®Google Scholar
• Ceriello A, Monnier L, Owens D. Glycaemic variability in diabetes: clinical and therapeutic implications. Lancet Diabetes Endocrinol. 2019;7(3):221–230. doi:10.1016/S2213-8587(18)30136-0
   PubMed Web of Science ®Google Scholar
• Gorst C, Kwok CS, Aslam S, et al. Long-term glycemic variability and risk of adverse outcomes: a systematic review and meta-analysis. Diabetes Care. 2015;38(12):2354–2369. doi:10.2337/dc15-1188
   PubMed Web of Science ®Google Scholar
• Forbes A, Murrells T, Mulnier H, Sinclair AJ. Mean HbA 1c, HbA 1c variability, and mortality in people with diabetes aged 70 years and older: a retrospective cohort study. Lancet Diabetes Endocrinol. 2018;6(6):476–486. doi:10.1016/S2213-8587(18)30048-2
   PubMed Web of Science ®Google Scholar
• Li S, Nemeth I, Donnelly L, Hapca S, Zhou K, Pearson ER. Visit-to-visit HbA1c variability is associated with cardiovascular disease and microvascular complications in patients with newly diagnosed type 2 diabetes. Diabetes Care. 2020;43(2):426–432. doi:10.2337/dc19-0823
   PubMed Web of Science ®Google Scholar
• Yang CY, Su PF, Hung JY, Ou HT, Kuo S. Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes. Cardiovasc Diabetol. 2020;19(1):1–10. doi:10.1186/s12933-020-01082-9
   PubMed Web of Science ®Google Scholar
• Lee S, Liu T, Zhou J, Zhang Q, Wong WT, Tse G. Predictions of diabetes complications and mortality using hba1c variability: a 10-year observational cohort study. Acta Diabetol. 2021;58(2):171–180. doi:10.1007/s00592-020-01605-6
   PubMed Web of Science ®Google Scholar
• Lim DYZ, Chia SY, Abdul Kadir H, Mohamed salim NN, Bee YM. Establishment of the SingHealth Diabetes Registry. Clin Epidemiol. 2021;13:215–223. doi:10.2147/CLEP.S300663
   PubMed Web of Science ®Google Scholar
• Lim DYZ, Wong TH, Feng M, Ong MEH, Ho AFW. Leveraging open data to reconstruct the Singapore Housing Index and other building-level markers of socioeconomic status for health services research. Int J Equity Health. 2021;20(1):218. doi:10.1186/s12939-021-01554-8
   PubMed Web of Science ®Google Scholar
• Chan CQH, Lee KH, Low LL. A systematic review of health status, health seeking behaviour and healthcare utilisation of low socioeconomic status populations in urban Singapore. Int J Equity Health. 2018;17(1):1–21. doi:10.1186/s12939-018-0751-y
   PubMed Web of Science ®Google Scholar
• StataCorp. Stata Statistical Software: Release 14. College Station, TX: StataCorp LP; 2015.
   Google Scholar
• Ministry of Trade and Industry - Department of Statistics. Singapore Residents By Age Group, Ethnic Group and gender, end June, annual-data; 2020. Available from: https://data.gov.sg/dataset/resident-population-by-ethnicity-gender-and-age-group. Accessed February 28, 2022.
   Google Scholar
• Perk J, De Backer G, Gohlke H, et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur Heart J. 2012;33(13):1635–1701. doi:10.1093/eurheartj/ehs092
   PubMed Web of Science ®Google Scholar
• Chia CW, Egan JM, Ferrucci L. Age-related changes in glucose metabolism, hyperglycemia, and cardiovascular risk. Circ Res. 2018;123(7):886–904. doi:10.1161/CIRCRESAHA.118.312806
   PubMed Web of Science ®Google Scholar
• Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–1589. doi:10.1056/nejmoa0806470
   PubMed Web of Science ®Google Scholar
• Stratton IM, Adler AI, Neil HAW, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br Med J. 2000;321(7258):405–412. doi:10.1136/bmj.321.7258.405
   PubMed Web of Science ®Google Scholar
• Ray KK, Seshasai SRK, Wijesuriya S, et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet. 2009;373(9677):1765–1772. doi:10.1016/S0140-6736(09)60697-8
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–853. doi:10.1016/S0140-6736(98)07019-6
   PubMed Web of Science ®Google Scholar
• Abraira C. Cardiovascular events and correlates in the veterans affairs diabetes feasibility trial. Arch Intern Med. 1997;157(2):181. doi:10.1001/archinte.1997.00440230053007
   PubMedGoogle Scholar
• Sciences HH, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545–2559. doi:10.1056/NEJMoa0802743
   PubMed Web of Science ®Google Scholar
• Heller SR. A summary of the ADVANCE Trial. Diabetes Care. 2009;32(Suppl 2):1–5. doi:10.2337/dc09-s339
   Google Scholar
• Rawshani A, Rawshani A, Franzén S, et al. Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2018;379(7):633–644. doi:10.1056/nejmoa1800256
   PubMed Web of Science ®Google Scholar
• Turner RC, Millns H, Neil HAW, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23). Br Med J. 1998;316(7134):823–828. doi:10.1136/bmj.316.7134.823
   PubMed Web of Science ®Google Scholar
• Ceriello A, Lucisano G, Prattichizzo F, et al. HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target. Cardiovasc Diabetol. 2022;21(1):1–9. doi:10.1186/s12933-022-01445-4
   PubMed Web of Science ®Google Scholar
• Raghavan S, Vassy JL, Ho YL, et al. Diabetes mellitus–related all-cause and cardiovascular mortality in a national cohort of adults. J Am Heart Assoc. 2019;8(4). doi:10.1161/JAHA.118.011295
   Web of Science ®Google Scholar
• Lind M, Imberg H, Coleman RL, Nerman O, Holman RR. Historical hba1c values may explain the type 2 diabetes legacy effect: ukpds 88. Diabetes Care. 2021;44(10):2231–2237. doi:10.2337/dc20-2439
   PubMed Web of Science ®Google Scholar
• Lau LH, Lew J, Borschmann K, Thijs V, Ekinci EI. Prevalence of diabetes and its effects on stroke outcomes: a meta-analysis and literature review. J Diabetes Investig. 2019;10(3):780–792. doi:10.1111/jdi.12932
   PubMed Web of Science ®Google Scholar
• Tsai CF, Anderson N, Thomas B, Sudlow CLM. Comparing risk factor profiles between intracerebral hemorrhage and ischemic stroke in Chinese and white populations: systematic review and meta-analysis. PLoS One. 2016;11(3):1–15. doi:10.1371/journal.pone.0151743
   Web of Science ®Google Scholar
• Rodrigues R, de Medeiros LA, Cunha LM, et al. Correlations of the glycemic variability with oxidative stress and erythrocytes membrane stability in patients with type 1 diabetes under intensive treatment. Diabetes Res Clin Pract. 2018;144:153–160. doi:10.1016/j.diabres.2018.01.031
   PubMed Web of Science ®Google Scholar
• Ohara M, Kohata Y, Nagaike H, et al. Association of glucose and blood pressure variability on oxidative stress in patients with type 2 diabetes mellitus and hypertension: a cross-sectional study. Diabetol Metab Syndr. 2019;11(1):1–10. doi:10.1186/s13098-019-0425-y
   PubMedGoogle Scholar
• Tan JK, Salim NNM, Hsiang Lim G, Yi ChiaID S, Thumboo J, Mong Bee Y. Trends in diabetes-related complications in Singapore, 2013–2020: a registry-based study. Sasso FC, ed. PLoS One. 2022;17(10):e0275920. doi:10.1371/JOURNAL.PONE.0275920
   PubMed Web of Science ®Google Scholar